Val and Wes publish on monster DEL-powered RNA ligand discovery

Wes and Val show that a DEL can be screened in flow to discover ligands of RNA secondary structures in a completely unbiased fashion. The DEL-derived ligands then plug directly into the Disney Lab’s two-dimensional combinatorial screening workflow, wherein a chosen ligand is used to fish out by selection its cognate RNA secondary structure target via deep sequencing. From there, the paper is the usual Disney tour-de-force transcriptomic target prediction and prosecution campaign. In this case, the DEL-derived molecule binds to pri-miR-27a, inhibiting miR-27a biogenesis and restoring expression of tumor migration repressors PDCD4 and PP4C. Congrats everyone on a job well done!

Paegel receives NIH MIRA

Great news! The NIH/NIGMS will continue to support our endeavors in activity-based DEL screening under the auspices of an R35 MIRA. A major new thrust includes tackling the problem of druggability and, specifically, enabling chemical probe discovery through the use of only one assay (akin to how DNA sequencers work).